Effect of ferric carboxymaltose on LVEF as assessed by cardiac MRI in patients with chronic heart failure and iron deficiency: a randomized, double-blinded, placebo-controlled, dual-center trial

26 May 2019 (10:30 - 10:36)

Organised by:

Abstract

Sign in to view the resources

About the speaker

Doctor Mahir Karakas

The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)

8 More presentations in this session

Presentation thumbnail

Association between heart failure medication at discharge and heart failure readmission

Doctor G. Linssen (Almelo, NL)

Abstract Slides

Presentation thumbnail

Association of loop diuretics use and dose with outcomes in outpatients with heart failure: a systematic review and meta-analysis involving 48,628 patients

Doctor C. Kapelios (Athens, GR)

Abstract Slides

Presentation thumbnail

Combined effects of growth hormone and testosterone replacement treatment in heart failure

Doctor A. Salzano (Naples, IT)

Presentation thumbnail

FE- IRON (First Ever Irish heart failure nurses group Review On implementation of ESC iroN guideline in Ireland)

Ms M. Carey (Dublin, IE)

Abstract Slides

Presentation thumbnail

Sacubitril/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in HFrEF.

Doctor P. Martens (Genk, BE)

Access the full session

Session thumbnail

Moderated Poster Session - Chronic heart failure

The Event

Heart Failure 2019

26 May 2019 10:30 CET

You may be interested in

Congress Session

Guideline-directed medical therapy implementation in special clinical scenarios

Congress Session

Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

Congress Session

Acute heart failure therapies: from clinical trials to clinical practice

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources